Stocktoria
Akebia Therapeutics, Inc. AKBA
Akebia Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 11,638,484 | $11.9M | 4.38% |
| AQR CAPITAL MANAGEMENT LLC | 9,151,524 | $10.4M | 3.45% |
| MILLENNIUM MANAGEMENT LLC | 3,196,605 | $3.6M | 1.2% |
| TWO SIGMA INVESTMENTS, LP | 2,436,673 | $2.8M | 0.92% |
| CITADEL ADVISORS LLC | 1,981,859 | $2.3M | 0.75% |
| RENAISSANCE TECHNOLOGIES LLC | 1,223,963 | $1.4M | 0.46% |
| D. E. Shaw & Co., Inc. | 87,722 | $100,003 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.